We found 4 drugmaker programs for Focal Epilepsy medicines and 1 charity fund (0 open at our last check). Tell us your insurance below and we'll show what to try first.
Help for Focal Epilepsy depends mostly on how you're covered. Pick the one that sounds like you. We'll name the funds and programs that fit, and what won't work, so you don't waste a phone call.
Independent foundations pay copays, coinsurance and sometimes insurance premiums for people who already have coverage. Funds open and close as donations come in, so each one shows what the foundation said on the date we checked.
Covers: Copays, coinsurance, deductibles and other health-related expenses.
Copay cards lower what people with private insurance pay. Federal rules bar them for Medicare, Medicaid and TRICARE. Free medicine programs are for people without enough coverage and usually have income limits. We read each program on the drugmaker's own site.
Commercially insured patients may pay as little as $10 per 30-day supply. Medicare, Medicaid, TRICARE, VA and other government plans excluded.
UCB Patient Assistance Program covers Briviact for uninsured/underinsured patients or those with hardship; household income up to 500% of poverty level.
UCB Direct: fills branded Briviact through a UCB-authorized pharmacy with insurance or self-pay options.
Savings card expires each calendar year. A generic is now available; the site says pharmacies may substitute generic unless instructed. UCBCares: 1-844-599-2273.
Eligible commercially insured patients may pay as little as $5; program pays up to $2,500 per year.
Cash-paying patients may get up to $60 off per prescription, up to $720 per year.
Patient assistance for uninsured US residents who meet income criteria; financial documents required. Anyone with commercial or government coverage is not eligible.
US rights to FYCOMPA are now held by Catalyst Pharmaceuticals (not Eisai); program pages and forms are Catalyst's. Savings card excludes Medicare, Medicaid, Medigap, VA, DoD and TRICARE. PAP phone on the official enrollment form: 1-888-392-6674 (fax 1-844-633-8444). The form states enrollment valid through Dec 31, 2025, so the form may be out of date. Generic perampanel is available; these programs cover brand FYCOMPA.
Free LAMICTAL, LAMICTAL XR and LAMICTAL ODT for uninsured US or Puerto Rico residents with no prescription coverage who meet household income limits.
Free LAMICTAL, LAMICTAL XR and LAMICTAL ODT for Medicare Part D patients who meet income limits and have spent $600 on prescriptions this calendar year.
Run by the GSK Patient Access Programs Foundation, a separate nonprofit. Covers the GSK brand (LAMICTAL, LAMICTAL XR and LAMICTAL ODT) only, not generic versions. Income limits apply (48 states/DC: $47,880 for 1 person, $99,000 for 4). GSK's copay and coupon program lists do not include LAMICTAL, LAMICTAL XR and LAMICTAL ODT. Generic lamotrigine is widely available.
Checks whether your insurance covers XCOPRI and provides prior authorization information.
Patient Assistance Program may provide XCOPRI free to eligible US residents who are uninsured, functionally uninsured or have financial hardship and meet a financial threshold.
Most eligible commercially insured patients may pay as little as $20 per month for refills. Eligibility requirements apply.
One-time $0 Trial Offer for a first 28-day starter prescription (12.5/25 mg). Not valid if the prescription is billed to Medicare or Medicaid.
Navigator may supply XCOPRI to eligible people starting treatment or experiencing coverage delays.
Navigator phone 1-866-SKNAVIG (756-2844), Mon-Fri 9am-6pm ET. The trial offer is not valid in Vermont and cannot be used to cover insurance delays. Pharmacy hotline for finding XCOPRI: 1-833-742-7675.
The drugmaker doesn't publish an assistance program for this medicine. Widely available as generic. Spritam is made by Aprecia, not UCB, and has its own savings program (spritam.com). Keppra is not on UCB's current copay or patient assistance lists.
The drugmaker doesn't publish an assistance program for this medicine. Widely available as generic from many makers. Vimpat is not on UCB's current copay or patient assistance lists.
Most of these programs start with one call, and having these ready makes it shorter. Tick them off as you go. Nothing here is saved or sent anywhere.
Call the drugmaker's support line first. Its case managers check your benefits and often fill out forms with your doctor. If a charity fund is closed, sign up on the foundation's page to hear when it reopens. Most programs need renewing every year, and many copay cards reset in January.
Yes. Trial Friend lists 4 drugmaker programs for Focal Epilepsy medicines and 1 charity fund, 0 of them open at our last check. We checked every one at the source on or before October 19, 2026. Which ones fit depends on your insurance. Copay cards are for people with private insurance, charity funds usually need some insurance, and free medicine programs are for people without enough coverage.
No. Federal rules bar drugmaker copay cards for drugs paid by Medicare, Medicaid or TRICARE. For Focal Epilepsy, 0 charity funds on this page accept Medicare, and 1 drugmaker free medicine program names Medicare patients among those who may qualify. In 2026, Medicare Part D also caps yearly out-of-pocket costs for covered drugs at $2,100.
None of the 1 fund listed for Focal Epilepsy was open to new applicants at our last check. Funds reopen when new donations arrive, and each foundation lets you sign up to hear when one opens.
Of the drugmaker programs for Focal Epilepsy medicines, 4 offer free medicine to people without insurance who qualify, usually with income limits. Most charity funds pay copays and premiums, so they need some insurance. The drugmaker's support line can also check whether you qualify for coverage you don't have yet.
How we check: drugmaker programs come only from each drugmaker's own pages. Fund status is copied from each foundation's list (The Assistance Fund) on the date shown. Programs change, so confirm with the program before you rely on it. Trial Friend shares information, not financial, legal or medical advice, and each program decides who qualifies. See something wrong? Email jason@trialfriend.com.
